Fundraising Fox

Amy Bachrodt

Chief Financial Officer at Lycia Therapeutics

South San Francisco, California, United States

Find your path to Amy

307 people in our graph share verified history with Amy — schools, employers, funds. One of them is your warm intro.

Sandra SchwarzerunlockedAmy: together at Ey (2002–2003)
×3Amy: together at Maze Therapeutics
Amy: together at Ey
×4Amy: together at Denison University

Chief Financial Officer at Lycia Therapeutics

Intro paths

→

In turn, Amy can intro founders to Lycia Therapeutics's investors below.

Lycia Therapeutics's investors · 11

BAM ElevateChicago · since 2026Franklin TempletonSan Mateo · since 2026HBM Healthcare InvestmentsZug · since 2026InvusNew York · since 2026Janus Henderson InvestorsLondon · since 2026OrbiMedNew York · $1M – $75M checks · since 2026REDMILESan FranciscoRTW Investments L.P.New York · since 2026Venrock Healthcare Capital PartnersNew York · since 2026Versant Venture CapitalSan Francisco · since 2020Versant VenturesSan Francisco · $250K – $5M checks · since 2026

Experience

  1. Lycia TherapeuticsChief Financial Officercurrent2026 — present
  2. The Association of Bioscience Financial Officers InternationalAFBO - Presidentcurrent2022 — presentSan Francisco County, CA
  3. Maze TherapeuticsSenior Vice President Finance2024 — 2026
  4. Maze TherapeuticsVP2021 — 2024
  5. Maze TherapeuticsSenior Director2020 — 2021South San Francisco, California, United States
  6. Myovant SciencesSenior Director2018 — 2020Brisbane, California
  7. GenentechAssociate Director, Revenue Analytics2017 — 2018
  8. GenentechAssociate Director, Gross to Net Commercial Discounts2014 — 2017San Francisco Bay Area
  9. GenentechLifeCycle Controller, Product Development Finance2012 — 2014
  10. GenentechSenior Manager, Supply Chain Finance2010 — 2012
  11. GenentechManager, Manufacturing Finance2008 — 2010
  12. Alvarez and MarsalManager, Disputes and Investigations2005 — 2008
  13. EYConsultant , Forensic and Integrity Services2002 — 2004
  14. Ernst & YoungAuditor, External Audit2001 — 2002

Skills & more

Financial AnalysisCash ManagementCorporate FP&AForecastingStrategyExternal AuditBiotechnologyFinance Business PartneringSupply ChainProduction PlanningProduct DevelopmentClinical Trials
+12 moreFinancial ForecastingFinancial AuditsInternal AuditFinancial ReportingCross-functional Team LeadershipManagementTeam LeadershipBudget OversightBusiness Partner SupportSOX 404Gross to netRevenue Forecasting
  • CPA

From Amy's professional profile.

Frequently asked questions

Who is Amy Bachrodt?
Chief Financial Officer at Lycia Therapeutics
Where does Amy Bachrodt work?
Amy Bachrodt is Chief Financial Officer at Lycia Therapeutics.
Where did Amy Bachrodt go to school?
Amy Bachrodt studied at University of Notre Dame - Mendoza College of Business (MSA, Accounting); Denison University (BA, Economics).

Same school

Also attended University of Notre Dame - Mendoza College of Business123

Ann PauloseSenior Investor Relations Associate at GreycroftJay JohnsonBoard Member at CincyTechDomenica CevallosAssociate at Fin CapitalMichael BrannanSr. Associate at Volition CapitalEdward KimInvestor at Side Door VenturesAmy PersohnChief Operating Officer at Navitas Capital

+ 117 more

Also attended Denison University64

Liz WesthouseHead of Community & Partnerships, Rise of the Rest at RevolutionAlex ConstantinopleChief Marketing Officer at GreycroftCatie MerrickDirector, Executive Talent Network at JMI EquityChrisInvestor at Perceptive Ventures Management Company, LlcGrace SchattnerChief of Staff at TitletownTechJoe MaxwellManaging Partner at FINTOP Capital

+ 58 more

Shared employers

Also worked at The Association of Bioscience Financial Officers International1

Herb CrossExecutive Officer at Jasper Therapeutics

Also worked at Maze Therapeutics12

Jeffrey FinerVenture Partner at Third Rock VenturesVyas RamananVenture Partner at Third Rock VenturesMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyMike VanAssociate, Private Equity at Sofinnova VenturesSudhir AgrawalInvestor at 82VSHugo HiltonPrincipal at Third Rock Ventures

+ 6 more

Also worked at Myovant Sciences5

Kara HolinskiFounder at ConfidoMichelle TsaiCOO at iOncturaVijay RajasekharFounder at DailyDoctorScott IsacksenExecutive Officer at KiyatecDavid MarekExecutive Officer, Director at ReAlta Life Sciences

Also worked at Genentech245

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 239 more